首页1尾页 共 17 条记录, 当前第1/1页。
MK-3102 Phase III Clinical Trial - Add-on to Oral Antihyperglycemic Agent Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-3102-015)
2012/9/28 12:00
Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: MK-3102;   Drug: Matching placebo to MK-3102;   Drug: Basal medication
Sponsors:   Merck;   Merck
Not yet recruiting - verified October 2012
A Study to Assess Safety and Efficacy of ASP1941 in Combination With Nateglinide in Type 2 Diabetic Patients
2011/3/14 12:00
Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: ASP1941;   Drug: nateglinide
Sponsor:   Astellas Pharma Inc
Recruiting - verified March 2011
Bioequivalence Study of Nateglinide Tablets 120 mg of Dr. Reddy's Laboratories Limited Under Fed Condition
2010/7/9 12:00
Condition:   Healthy
Intervention:   Drug: Nateglinide
Sponsor:   Dr. Reddy's Laboratories Limited
Completed - verified September 2004
Bioequivalence Study of Nateglinide Tablets 120 mg of Dr. Reddy's Laboratories Limited Under Fasting Condition
2010/7/8 12:00
Condition:   Healthy
Intervention:   Drug: Nateglinide
Sponsor:   Dr. Reddy's Laboratories Limited
Completed - verified January 2007
Effects of Nateglinide on Postprandial Glucose Excursion by Restoring Early Phase Insulin Secretion: Optimal Glycemic Control
2009/12/11 12:00
Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Nateglinide;   Drug: Acarbose
Sponsor:   Novartis
Recruiting - verified October 2010
Effects of Nateglinide vs. Acarbose on Postprandial Glucose Fluctuation, Dyslipidemia and Inflammatory Factors
2009/6/25 12:00
Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Nateglinide;   Drug: Acarbose
Sponsor:   Novartis
Active, not recruiting - verified October 2010
Study of the Durability of Glycemic Control With Nateglinide
2009/3/6 12:00
Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: Nateglinide;   Drug: Glimepiride
Sponsors:   Ajou University School of Medicine;   Korea University Guro Hospital;   Hanyang University;   Inha University Hospital;   Kyunghee University Medical Center
Not yet recruiting - verified March 2009
Double-Blind Comparison Between Mitiglinide and Nateglinide in Type 2 Diabetic Patients
2007/4/17 12:00
Condition:   Diabetes
Intervention:   Drug: Mitiglinide
Sponsor:   Kissei Pharmaceutical Co., Ltd.
Completed - verified April 2007
The Effects of Nateglinide and Acarbose on the Post-Prandial Glucose Control in Type 2 Diabetic Patients
2007/2/20 12:00
Conditions:   Diabetes Mellitus;   Type 2 Diabetes Mellitus
Interventions:   Drug: nateglinide;   Drug: acarbose
Sponsors:   Inje University;   Sanofi-Aventis
Completed - verified March 2008
Safety and Efficacy of Nateglinide in Patients With Type 2 Diabetes Already Taking Insulin Glargine, Metformin and/or Pioglitazone or Rosiglitazone
2006/11/20 12:00
Condition:   Type 2 Diabetes
Intervention:   Drug: Nateglinide
Sponsor:   Novartis
Completed - verified September 2007
Combination of Glinides With Premixed Insulin
2006/8/28 12:00
Condition:   Type 2 Diabets Mellitus
Intervention:   Drug: nateglinide(drug) mitiglinide(drug)
Sponsor:   Keio University
Completed - verified August 2009
Efficacy and Safety of Nateglinide Treatment in Renal Transplant Recipients
2006/4/27 12:00
Conditions:   Renal Transplant Recipients;   Posttransplant Diabetes Mellitus;   Posttransplant Impaired Glucose Tolerance
Intervention:   Drug: Nateglinide
Sponsor:   University of Oslo School of Pharmacy
Completed - verified April 2006
Insulin Resistance and Vessel Function After Meals: Does Early Intervention Make a Difference?
2005/11/28 12:00
Conditions:   Insulin Resistance;   Impaired Fasting Glucose
Intervention:   Drug: Nateglinide
Sponsors:   Bispebjerg Hospital;   Novartis;   Bayer
Recruiting - verified November 2005
A Pilot Study to Evaluate the Effects of Nateglinide Vs. Glibenclamide on Renal Hemodynamics and Albumin Excretion
2005/10/12 12:00
Condition:   Diabetes Mellitus, Type 2
Intervention:   Drug: nateglinide
Sponsor:   Novartis
Completed - verified June 2006
Insulin Resistance and Central Nervous System (CNS) Function in Type 2 Diabetes
2005/9/20 12:00
Conditions:   Insulin Resistance;   Type 2 Diabetes Mellitus
Interventions:   Drug: pioglitazone;   Drug: nateglinide;   Drug: placebo
Sponsor:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Completed - verified February 2010
Nateglinide: a Double Blind Add-on Study With Pioglitazone for Type 2 Diabetic Patients
2005/9/13 12:00
Conditions:   Type 2 Diabetes Mellitus;   Diabetes Mellitus, Type II
Intervention:   Drug: nateglinide
Sponsors:   Astellas Pharma Inc;   Ajinomoto USA, INC.
Completed - verified March 2008
Long-term Study of Nateglinide+Valsartan to Prevent or Delay Type II Diabetes Mellitus and Cardiovascular Complications
2004/11/30 12:00
Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Valsartan 160 mg + nateglinide 60 mg;   Drug: Valsartan 160 mg + nateglinide placebo;   Drug: Nateglinide 60 mg + valsartan placebo;   Drug: Valsartan placebo + nateglinide placebo
Sponsor:   Novartis Pharmaceuticals
Completed - verified April 2011